Peregrine shares surge on regulatory pact for late-stage cancer drug; AZ hunts for spot for new R&D complex;

 @FierceBiotech:  Life sciences VC firm launches 'crowdfunding' site for limited crowd. More | Follow @FierceBiotech

 @JohnCFierce: Pentagon advisor pocketed biotech's cash while promoting its interests - via LATimes. Report | Follow @JohnCFierce

 @RyanMFierce: Interesting 'Open Research Exchange' platform debuts for creating outcome measures from the crowd. Release | Follow @RyanMFierce

> Shares of Peregrine Pharmaceuticals ($PPHM) shot up 19% early today after the biotech reported that it had reached an agreement with the FDA on the design of a late-stage study of the cancer drug bavituximab. The primary focus is on overall survival compared to chemotherapy. Story

> AstraZeneca ($AZN) officials are reportedly looking closely at a biomedical park near Cambridge in the U.K. as a likely site for its planned $500 million R&D complex, a central feature in its restructuring. Story

> Over the weekend Lundbeck touted Phase III data for the depression drug Brintellix (vortioxetine) demonstrating improvements in patients' symptoms. Report

> The Boston Globe reports on the nanotech work being done by biotech entrepreneur Omid Farokhzad, a close associate of MIT's Robert Langer. Story

Medical Device News

 @FierceMedDev:  Shoe-mounted lever could power artificial heart pumps. More | Follow @FierceMedDev

 @MarkHFierce: Check out FierceDrugDelivery's latest - a great look at some advances in nanotech drug delivery. Special report | Follow @MarkHFierce

 @DamianFierce:  PRA is lining up to go public, filing a confidential draft with the SEC. Article | Follow @DamianFierce

> FDA slaps deadly label on Abbott's glucose meter recall. News

> PIP attorneys plead for leniency in breast implant fraud trial. Report

> Medtronic wins CE mark for clot-removal tech. More

Pharma News

 @FiercePharma: Biopharma's 20 highest-paid CEOs. Our latest special report on exec pay. Report | Follow @FiercePharma

 @EricPFierce: AstraZeneca rides Crestor to top of cardio drug list. Special report | Follow @EricPFierce

> Women want Apotex to pay for unwanted pregnancies. Article

> Actavis nabs Warner Chilcott in a $8.5B stock swap. News

> JVs like Pfizer, Hisun hookup provide Chinese companies shot at Western markets. Report

CRO News

> Nordion inks CMO deal with Navidea. Report

> After successful IPO, Quintiles plots 400 job cuts. Item

> PRA winds up for IPO. News

> Quintiles signs on to help Merck KGaA right the R&D ship. More

> PPD's BioDuro opens Shanghai discovery lab. Story

>WuXi's revenue jumps 11.7% in strong Q1. Article

Biotech IT News

> Drugmaker UCB taps IBM for digital medicine effort. Article

> InSilico Genomics grabs $1.5M for fledgling bioinformatics biz. Report

> Life sciences VC firm launches 'crowdfunding' site for limited crowd. Article

> Sanofi hunts for clinical trial recruits in growing social network. Story

> Merck targets docs with revamped U.K. website and healthcare apps. News

And Finally… Should we be wary of genomics' potential to treat cancer better? Blog